title: [2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines].
authors.affiliation: jose_zamorano_@op.pl.
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Zamorano
authors.forename: Patrizio
authors.initials: P
authors.lastname: Lancellotti
authors.forename: Daniel Rodriguez
authors.initials: DR
authors.lastname: Muñoz
authors.forename: Victor
authors.initials: V
authors.lastname: Aboyans
authors.forename: Riccardo
authors.initials: R
authors.lastname: Asteggiano
authors.forename: Maurizio
authors.initials: M
authors.lastname: Galderisi
authors.forename: Gilbert
authors.initials: G
authors.lastname: Habib
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Lenihan
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
authors.forename: Alexander R
authors.initials: AR
authors.lastname: Lyon
authors.forename: Teresa Lopez
authors.initials: TL
authors.lastname: Fernandez
authors.forename: Dania
authors.initials: D
authors.lastname: Mohty
authors.forename: Massimo F
authors.initials: MF
authors.lastname: Piepoli
authors.forename: Juan
authors.initials: J
authors.lastname: Tamargo
authors.forename: Adam
authors.initials: A
authors.lastname: Torbicki
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Suter
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity*; D002309:Cardiology; D066126:Cardiotoxicity; D005060:Europe; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D012955:Societies, Medical
chemical_list: D000970:Antineoplastic Agents